 |
市场调查报告书
商品编码
1555671
340B 药品价格管理系统（2024）：供应商是否在高能量市场中推动节省？340B Management Systems 2024 Are Vendors Driving Savings in a High-Energy Market? |
||||||
340B药品价格管理方案是一个持续高能量的市场，对于被分析的医疗机构来说，由于寻求降低组织和病患的成本而成为首要问题。随着药品製造商的法规强化，并且未来法规有可能进一步加强，医疗保健组织继续向 340B 价格管理供应商寻求工具和专业知识来驾驭这一领域。本报告分析并提供客户对340B 药品价格管理供应商的满意度，各种类型客户的使用情况、客户节省和有效利用的趋势、供应商支持的水准以及如何应对日益成长的挑战等资讯。
目录
高阶主管洞察力
供应商见解
资料指标
A market with consistently high energy, 340B programs remain top of mind for eligible healthcare organizations as they try to drive cost savings for both their organization and their patients. With increasing drug manufacturer restrictions and the possibility of additional legislation down the road, organizations continue to look to their 340B management vendors for tools and expertise to help navigate this space. This report examines customer satisfaction with 340B management vendors by looking at factors such as use by different customer types, customer ability to find savings and get their money's worth, strength of vendor support, and vendor guidance in managing evolving challenges.
Table of Contents
2-Executive Insights
8-Vendor Insights
14-Data Index
